Kontour (Xi'an) Medical Technology Co., Ltd. (SHA:688314)
China flag China · Delayed Price · Currency is CNY
25.97
-0.89 (-3.31%)
Nov 13, 2026, 3:00 PM CST

SHA:688314 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
350.81341.87311.71262.63229.61206.31
Other Revenue
9.29.210.2312.410.346.24
360.01351.08321.95275.03239.95212.55
Revenue Growth
8.14%9.05%17.06%14.62%12.89%29.54%
Cost of Revenue
82.5776.7967.9360.3850.1941.99
Gross Profit
277.44274.28254.01214.65189.76170.56
Selling, General & Admin
143.3121.19119.76107.3391.5875.18
Research & Development
34.3225.6423.917.6418.316.8
Other Operating Expenses
0.94.584.644.424.032.77
Operating Expenses
178.82152.02147.96129.38114.1194.71
Operating Income
98.61122.26106.0585.2675.6475.85
Interest Expense
-0.63-2.32-2.17-1.89-1.23-0.74
Interest & Investment Income
0.252.035.225.28.144.85
Currency Exchange Gain (Loss)
0.150.15-0.370.230.490.03
Other Non Operating Income (Expenses)
-5.85-0.72-1.75-0.3-0.2-0.17
EBT Excluding Unusual Items
92.53121.4106.9888.582.8579.82
Impairment of Goodwill
-2.19-2.19----
Gain (Loss) on Sale of Investments
0.33-9.21-12.59-1.86--
Gain (Loss) on Sale of Assets
-0.37-0.380.44-0.06-00.02
Asset Writedown
-2.13--1.87--0.04-0.35
Other Unusual Items
6.085.8913.045.185.6615.9
Pretax Income
94.25115.5210691.7588.4695.39
Income Tax Expense
12.7117.7718.3717.2814.314.21
Earnings From Continuing Operations
81.5497.7587.6474.4774.1681.18
Minority Interest in Earnings
1.750.960.761.041.530.44
Net Income
83.2998.788.475.5175.6981.63
Net Income to Common
83.2998.788.475.5175.6981.63
Net Income Growth
-5.78%11.66%17.07%-0.23%-7.28%55.83%
Shares Outstanding (Basic)
828281818173
Shares Outstanding (Diluted)
828281818173
Shares Change
0.69%0.58%-0.12%-0.23%11.81%19.10%
EPS (Basic)
1.021.211.090.930.931.12
EPS (Diluted)
1.021.211.090.930.931.12
EPS Growth
-6.43%11.01%17.20%0%-17.07%30.84%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
65.9466.6592.867173.7848.05
Free Cash Flow Per Share
0.810.821.150.870.910.66
Dividend Per Share
0.3200.5200.3600.3200.3710.443
Dividend Growth
-15.79%44.44%12.50%-13.84%-16.14%19.25%
Gross Margin
77.06%78.13%78.90%78.05%79.08%80.25%
Operating Margin
27.39%34.83%32.94%31.00%31.52%35.69%
Profit Margin
23.14%28.12%27.46%27.46%31.54%38.40%
Free Cash Flow Margin
18.32%18.98%28.84%25.82%30.75%22.61%
EBITDA
112.53135.15117.5695.6285.5683.02
EBITDA Margin
31.26%38.50%36.52%34.77%35.66%39.06%
D&A For EBITDA
13.9212.8811.5110.369.917.17
EBIT
98.61122.26106.0585.2675.6475.85
EBIT Margin
27.39%34.83%32.94%31.00%31.52%35.69%
Effective Tax Rate
13.49%15.38%17.33%18.83%16.17%14.90%
Revenue as Reported
99.99351.08321.95275.03239.95212.55
Advertising Expenses
-12.8415.9317.7719.9717.68